MedPath

Intrapartum monitoring: a prospective observational cohort

Recruiting
Conditions
Every patient who delivers at our clinic
Registration Number
NL-OMON25099
Lead Sponsor
ot applicable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
3000
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria: pregnant women who are admitted to the labor ward because of (induction of) labor or postpartum women who delivered at the labor ward with fetal monitoring during delivery, carrying at least one living fetus. Patients are only included after oral and written informed consent.

Exclusion Criteria

None, monitoring standard care

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main goal of this prospective observational study is to collect data to record maternal and neonatal outcomes of fetal monitoring during labour by using the conventional CTG (DU or FSE and TOCO). The collected data will be control data for an implementation study for the NI-fECG, which will be performed later this year.<br><br>Maternal outcomes: episiotomy and its indication, spontaneous vaginal deliveries and operative deliveries (vacuum extractions or caesarean section) with indication (fetal distress and/or failure to progress).<br>Neonatal outcomes: FBS during delivery, birth weight, gender, Apgar score, admission to a neonatal ward, pH in umbilical artery and vein.
Secondary Outcome Measures
NameTimeMethod
The rate of deliveries in which placement of FSE was used, and how often FBS was performed.<br>Complications during delivery and postpartum: shoulder dystocia, intrapartum maternal fever, eclampsia, postpartum hemorrhage, thrombosis, wound infection, endometritis, mastitis.<br><br>This study serves as an important step towards prospective observational collection of data concerning monitoring during delivery on a larger scale. In addition, big data will provide reliable results concerning outcomes of obstetrical care in different subgroups in secondary and tertiary obstetric clinics.
© Copyright 2025. All Rights Reserved by MedPath